Founder, Chairman & CEO

Co-founder and VP of Technology

Stem Cell Banking Market Projected to Reach US$ 27.95 Billion by 2035, Supported by Advancing Clinical Development Activity | Astute Analytica

Alamar's 2025 Revenues Nearly Triple Year Over Year; Firm Releases Five-Plex Alzheimer's Assay

Alamar Biosciences Raises $50M, Joins Alzheimer's Disease Research Program

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research

Scientist I – Technology Access Program

Alamar Biosciences, Inc. is focused on enabling scientific discoveries that lead to clinical outcomes. They are seeking a highly motivated Scientist to join their Technology Access team, where the role involves designing and executing NULISA immunoassay projects while collaborating with various teams.

0.800000011920929

Scientist II – Technology Access Program

Alamar Biosciences, Inc. is dedicated to enabling scientific discoveries that lead to clinical outcomes. They are seeking a highly motivated Scientist II to design, execute, and analyze experimental studies for client-sponsored research projects, with a focus on assay development and large proteomic datasets.

Scientist I – Technology Access Program in united states (1000+)

Scientist I – Technology Access Program

Scientist II – Technology Access Program